R. Brent Wisner received a JD from Georgetown University in Washington, D. C.. During his prosperous career as an attorney, R. Brent Wisner has become the vice president of Baum Hedlund Aristei & Goldman. This major law firm handles truck accident lawsuits across the country, among other types of major accidents and pharmaceutical and consumer mass torts.
Truck accidents can be incredibly devastating to passenger vehicle occupants and complex to litigate. Since a truck can weigh more than 80,000 pounds when fully loaded, it can cause significant destruction and injuries to objects and persons involved. Each truck accident involves at least the trucker, the company they work for, the vehicle manufacturer, and the owner of the load carried in the truck. The trucking company will often look at its bottom line and protect its interests when working with insurance adjusters. An attorney with experience in trucking accidents knows how the various companies operate and the lengths they will go to defend themselves from paying huge fines and settlements. One of the essential pieces of information needed during truck crashes is the record log which companies can falsify or even destroy after a certain time. This makes truck accident litigation more complex to solve and requires an expert lawyer.
0 Comments
R. Brent Wisner obtained a JD from Georgetown University and started his career as a litigation attorney. Over the course of his career, he managed to secure a $2 billion settlement in the famous Monsanto Roundup case. R. Brent Wisner is currently the vice president of Baum Hedlund Aristei & Goldman, one of the most successful law firms in the country. Their lawyers are currently representing people in the Zantac lawsuits.
Zantac is one of the most popular over-the-counter medicine, and the first one to reach $1 billion in sales. However Zantac contains ranitidine which has been shown in numerous studies to contain NDMA (N-nitrosodimethylamine). This cancerogenic compound has been linked to several types of cancer, including breast, bladder, prostate, liver cancers, and melanomas. Studies have shown that as little as 148 ng per 100 grams per day is enough to increase the incidence of cancers in humans. In a recent study, ranitidine has been found to increase the NDMA level in the drug to critical limits in the people’s stomach, going up to 3100 times to recommended daily dosage. The manufacturer recalled the drug in April 2020 and replaced it with a medicine that doesn’t contain ranitidine. A successful attorney and resident of Los Angeles, R. Brent Wisner holds both a juris doctor and a master of public policy from Georgetown University. R. Brent Wisner obtained two landmark verdicts and also received much recognition for his work on Monsanto’s herbicide Roundup litigation.
Roundup weed killer, a glyphosate-based herbicide, has been designated as a potent human carcinogen (cancer-causing substance) by the International Agency for Research on Cancer (IARC). The herbicide is manufactured by Monsanto (now called Bayer). People who have used Roundup weed killers such as gardeners, farmers, and agricultural workers have high chances of developing a certain lymphatic system cancer called non-Hodgkin lymphoma, among other cancers. Three cases have been successfully tried against Monsanto, resulting in verdicts totaling $2.42 billion. Since the affected population has to go through the challenges of massive medical bills, consumers and individuals who were exposed to Roundup need to be compensated for their injuries. The Monsanto Roundup lawsuit was designed to ensure this justice. A partner and vice president at Baum, Hedlund, Aristei, and Goldman, R. Brent Wisner helped represent plaintiffs who won landmark judgments against Monsanto. Because of their significance, R. Brent Wisner has been invited to speak on the cases at high-profile institutions such as Yale University.
Before his talk at Yale, students were already involved with an initiative that would address the impact of Monsanto’s agro-chemical business globally. A group of Yale law students traveled to the Netherlands in 2016 to take part in the Monsanto Tribunal, an international initiative whose purpose was to hold Monsanto accountable for what it alleged were violations of human rights and crimes against humanity. The tribunal’s purpose was to help advance humanitarian and human rights laws. Teams investigated whether the company engaged in activities that violated rights to a healthy, sustainable environment as defined by international laws governing human rights. This tribunal met long before the cases in California came to trial and were settled. Because of the size of the awards in the Monsanto cases in California ($289 million in one case and over $2 billion in the other), and the fact that the court found the company to be both negligent and to act with malice, these landmark cases might ultimately have global implications for the corporation. To add to its problems, it is presently facing similar complaints from several thousand people in separate cases. |